Literature DB >> 19782069

RhoB enhances migration and MMP1 expression of prostate cancer DU145.

Misao Yoneda1, Yoshifumi S Hirokawa, Atsuyuki Ohashi, Katsunori Uchida, Daisuke Kami, Masatoshi Watanabe, Toyoharu Yokoi, Taizo Shiraishi, Shinya Wakusawa.   

Abstract

Rho family protein regulates variety of cellular functions as cytoskeletal organization, cell proliferation and apoptosis. In the present study, we demonstrate that RhoB-overexpressed prostate cancer cells showed an enhanced cell motility and the administration of the GSK-3 inhibitors inhibited this increase in migration. Among the extracellular matrix and adhesion-related molecules, MMP1 RNA expression was increased in RhoB-overexpressed cells, administration of MMP inhibitor suppressed the collagen gel invasion in these cells. This is the first report evaluating RhoB function and the downstream signaling events in prostate cancer cell. Our results indicate that RhoB promotes cell motility and invasion in a metastatic prostate cancer cell. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782069     DOI: 10.1016/j.yexmp.2009.09.010

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  6 in total

1.  Role of RhoB in the regulation of pulmonary endothelial and smooth muscle cell responses to hypoxia.

Authors:  Beata Wojciak-Stothard; Lan Zhao; Eduardo Oliver; Olivier Dubois; Yixing Wu; Dimitris Kardassis; Eleftheria Vasilaki; Minzhou Huang; Jane A Mitchell; Louise S Harrington; Harrington Louise; George C Prendergast; Martin R Wilkins
Journal:  Circ Res       Date:  2012-04-26       Impact factor: 17.367

2.  ROCK1 & 2 perform overlapping and unique roles in angiogenesis and angiosarcoma tumor progression.

Authors:  J Montalvo; C Spencer; A Hackathorn; K Masterjohn; A Perkins; C Doty; A Arumugam; P P Ongusaha; R Lakshmanaswamy; J K Liao; D C Mitchell; B A Bryan
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

3.  CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis.

Authors:  Lei Jin; Wei-Ren Liu; Meng-Xin Tian; Xi-Fei Jiang; Han Wang; Pei-Yun Zhou; Zhen-Bin Ding; Yuan-Fei Peng; Zhi Dai; Shuang-Jian Qiu; Jian Zhou; Jia Fan; Ying-Hong Shi
Journal:  Oncotarget       Date:  2017-01-17

4.  Integrin α2β1 decelerates proliferation, but promotes survival and invasion of prostate cancer cells.

Authors:  Marjaana Ojalill; Marjaana Parikainen; Pekka Rappu; Elina Aalto; Johanna Jokinen; Noora Virtanen; Elina Siljamäki; Jyrki Heino
Journal:  Oncotarget       Date:  2018-08-21

5.  Modeling truncated AR expression in a natural androgen responsive environment and identification of RHOB as a direct transcriptional target.

Authors:  Hui-Chi Tsai; David L Boucher; Anthony Martinez; Clifford G Tepper; Hsing-Jien Kung
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

Review 6.  RhoB: Team Oncogene or Team Tumor Suppressor?

Authors:  Julia A Ju; Daniele M Gilkes
Journal:  Genes (Basel)       Date:  2018-01-30       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.